Response to Forrest et al

Affiliations

¹ Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama.
² Division of Gastroenterology and Hepatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
³ Division of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, Oregon.
⁴ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Comment

Ashwani K Singal et al. Am J Gastroenterol. 2019 Jan.

. 2019 Jan;114(1):176.

doi: 10.14309/ajg.0000000000000073.

¹ Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama.
² Division of Gastroenterology and Hepatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
³ Division of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, Oregon.
⁴ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

No abstract available

Comment on

ACG Clinical Guideline: Alcoholic Liver Disease.
Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. Singal AK, et al. Am J Gastroenterol. 2018 Feb;113(2):175-194. doi: 10.1038/ajg.2017.469. Epub 2018 Jan 16. Am J Gastroenterol. 2018. PMID: 29336434 Free PMC article.
ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established.
Forrest EH, Atkinson SR, Richardson P, Masson S, Ryder S, Thursz MR, Allison M. Forrest EH, et al. Am J Gastroenterol. 2019 Jan;114(1):175-176. doi: 10.1038/s41395-018-0076-x. Am J Gastroenterol. 2019. PMID: 29887598 No abstract available.